Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CanniMed Therapeutics (CMED) is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry. In addition, CMED has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. CanniMed Therapeutics operates as a biopharmaceutical company. The Co...
CanniMed Therapeutics (CMED) is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry. In addition, CMED has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. CanniMed Therapeutics operates as a biopharmaceutical company. The Company focuses on producing pharmaceutical-grade cannabis through research and development, as well as through collaborations with external partners, including academic institutions and healthcare professionals.

List your booth number for exhibitions, ask us